交銀國際(03329.HK)出售1,000萬美元債券 料錄虧損逾55萬美元
交銀國際(03329.HK)公布,於11月30日至12月5日期間,其直接全資附屬Preferred Investment已於公開市場出售本金總額為1,000萬美元(約7,850萬港元)之債券,總代價為約926.23萬美元(約7,270.92萬港元)。該債券到期日為2024年11月17日,票面息率為每年1.75厘。
公司預期,出售事項將產生未經審核虧損約為55.19萬美元(約433.23萬港元);所得款項擬用於集團之一般營運資金,倘出現任何合適投資機會,公司亦可動用部分所得款項作新投資用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.